Bertolotti's Syndrome: Diagnosis and Management
Start with plain radiographs of the lumbar spine to identify lumbosacral transitional vertebrae (LSTV), then confirm the diagnosis with fluoroscopy-guided diagnostic injections at the pseudoarticulation before initiating treatment—this is the only way to distinguish incidental anatomical findings from true pain generators. 1, 2
Diagnostic Approach
Initial Imaging
Begin with standing anteroposterior and lateral radiographs of the lumbar spine to identify LSTV. Look specifically for:
- Enlarged transverse processes of L5
- Pseudoarticulation between L5 transverse process and sacral ala (Castellvi Type II)
- Complete or partial sacralization (Castellvi Types III-IV)
The critical pitfall: 33% of patients with LSTV go undiagnosed because providers fail to recognize the anatomical variant on imaging 1. This leads to unnecessary injections at wrong levels and delayed appropriate treatment.
Confirmatory Diagnosis
Fluoroscopy-guided diagnostic injection at the pseudoarticulation is mandatory to confirm the LSTV is the actual pain source 1, 2. This distinguishes Bertolotti's syndrome from incidental LSTV findings. Patients who receive targeted pseudoarticulation injections show significantly better immediate symptom relief compared to injections at other spinal levels (p = 0.002) 1.
Clinical Presentation to Recognize
- Chronic low back pain in patients aged 20-40 years 3, 4
- Pain in sacroiliac joint, groin, hip region 4
- May include radiculopathy in L5 distribution 5, 6
- Pain worsens with activity, bending, squatting 7
Treatment Algorithm
Step 1: Conservative Management (6 weeks minimum)
- NSAIDs for pain control
- Physical therapy focusing on lumbar flexibility and core strengthening
- Activity modification
- Consider myofascial release targeting thoracolumbar fascia and quadratus lumborum 6
This aligns with general low back pain guidelines that recommend conservative therapy before imaging in uncomplicated cases 8, 9.
Step 2: Injection Therapy (if conservative fails)
Target the pseudoarticulation specifically with fluoroscopy guidance using:
- Local anesthetic alone, or
- Local anesthetic plus corticosteroid 4
Patients receiving pseudoarticulation injections have significantly better outcomes than those receiving injections elsewhere 1. Undiagnosed patients undergo more total injections with less benefit because injections are misdirected to other spinal levels 1.
Alternative: Epidural steroid injection at the level of transitional articulation 4
Step 3: Advanced Interventional Options
If injections provide temporary relief but symptoms recur, consider:
- Radiofrequency ablation (RFA) around the transitional segment 4
Step 4: Surgical Management (refractory cases only)
Reserve surgery for patients who:
- Fail 6+ weeks of conservative management
- Fail injection therapy
- Have confirmed diagnosis via positive diagnostic injection
- Demonstrate significant functional impairment
Surgical options:
- Pseudoarthrectomy (resection of anomalous transverse process) - Primary option 10, 1
- Posterior spinal fusion - Alternative approach 5
- Decompression if foraminal stenosis present 4
Surgical outcomes are superior to continued injections alone in properly selected patients (p < 0.001) 1. All patients in recent surgical series showed significant sustained improvement at 6-24 months with no neurological complications 10.
Critical Clinical Pearls
The diagnostic injection is non-negotiable. Without confirming the LSTV causes pain, you risk treating an incidental finding while the true pain generator remains unaddressed 2. LSTV prevalence ranges 4-36%, but only a fraction develop symptomatic Bertolotti's syndrome 4.
Patients who respond well to pseudoarticulation injections are the ideal surgical candidates 1. This positive response predicts surgical success.
Avoid the common error of multiple non-targeted injections. Diagnosed patients undergo fewer total injections than undiagnosed patients (p = 0.031) because treatment is appropriately directed 1.
The condition is particularly underdiagnosed in younger patients and adolescents, though early recognition allows for optimal pain management 7. Most symptomatic cases present in the 30-40 age range 3.